Endometriosis Treatment Market Analysis 2019: Ipsen Pharma, Myovant Sciences Ltd, Endoceutics, Inc., Debiopharm Group, Others and Forcast to 2028
The endometriosis treatment market is likely to exceed US$ 2.5 Bn in 2019, as per the findings of a recently published research study by FMI. According to the study, demand for endometriosis treatment is envisaged to grow against the backdrop of wide-spread prevalence of endometriosis affecting women, notably those in the reproductive age-group.
View full press release